导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.96% | 2054/2282 |
| 近一周 | -3.81% | 2093/2314 |
| 近一月 | -6.30% | 2053/2307 |
| 近一季 | -14.04% | 1796/2292 |
| 近半年 | -16.42% | 2087/2290 |
| 近一年 | -5.92% | 1794/2265 |
| 近两年 | 60.68% | 817/2173 |
| 近三年 | 22.30% | 1054/2101 |
| 成立以来 | 165.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.58% 1885/2333 |
0.44% 1652/2331 |
- - |
- - |
| 2025 | 52.89% 274/2338 |
8.35% 266/2326 |
5.34% 449/2347 |
30.52% 545/2344 |
2.64% 568/2338 |
| 2024 | -6.04% 1904/2331 |
-2.62% 1375/2322 |
-8.26% 2058/2326 |
6.61% 1343/2317 |
-1.34% 1265/2331 |
| 2023 | 0.27% 385/2323 |
8.14% 345/2290 |
2.92% 170/2303 |
-8.10% 1465/2318 |
-1.97% 868/2330 |
| 2022 | -19.14% 1252/2294 |
-12.78% 1077/2227 |
10.60% 412/2269 |
-10.37% 1346/2294 |
-6.48% 1966/2300 |
| 2021 | 14.87% 518/2202 |
-13.55% 1919/2009 |
19.08% 310/2060 |
7.16% 269/2103 |
4.13% 663/2208 |
| 2020 | 28.08% 1180/2082 |
3.28% 339/1861 |
23.55% 492/1950 |
-6.33% 1934/2010 |
7.16% 1141/2031 |
| 2019 | 52.07% 274/1973 |
29.93% 445/3053 |
-5.15% 2586/3201 |
15.60% 79/1861 |
6.75% 906/1886 |
| 2018 | -23.82% 1304/1913 |
- - |
-18.17% 2837/2983 |
-3.49% 1547/2970 |
-3.97% 1121/2975 |
| 2017 | 0.41% 1315/1885 |
- - |
- - |
- - |
- - |
| 2016 | 8.16% 47/1510 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 前海开源医疗健康A | 1.3221 | 43.69% |
| 前海开源医疗健康C | 1.3108 | 43.67% |
| 中信建投医改混合A | 1.9439 | 35.61% |
| 中信建投医改混合C | 1.5821 | 35.48% |
| 国投瑞银医疗保健混合C | 1.1874 | 26.59% |
| 易方达供给改革混合 | 8.1305 | 24.38% |
| 国投瑞银医疗保健混合A | 1.2015 | 24.11% |
| 浦银安盛医疗健康混合A | 1.3373 | 24.10% |
| 先锋聚优A | 1.3980 | 23.90% |
| 先锋聚优C | 1.4204 | 23.84% |
| 华商双驱优选混合 VS. 德邦优化A(770001) |